Lab21

  • Lab21 expands international business with launch into India

    Lab21’s immunodiagnostic division has entered into a substantial distribution agreement with Inverness Medical India (Spectral Diagnostics Pvt. Ltd) to supply more than 500,000 TPHA kits for the diagnosis of syphilis. This initial contract will…

    Lab21 | 11 November 2008

  • Lab21 to market deCODE BreastCancer

    Lab21 says it will be building on its’ strong molecular diagnostics portfolio with the addition of deCODE BreastCancer, which will be available across the UK and Ireland. deCODE‘s BreastCancer assay can be used to predict a woman’s lifetime…

    Lab21 | 13 October 2008

  • Tests for Assessing Risk of Common Diseases

    Lab21 Limited says it has entered into a partnership with deCODE genetics to offer deCODE's tests for predisposition to a growing number of common diseases. The license allows Lab21 to offer its clients in the UK and Ireland access to new tests for …

    Lab21 | 01 September 2008